Eveline M Gutzwiller
evelinemg.bsky.social
Eveline M Gutzwiller
@evelinemg.bsky.social
🇨🇭 Geneva-born Neurologist | Neuroscientist | Founding Director, Neurocritical care in NY | Building the next-gen NSICU | Driving Neuroscience Innovation
Presented our NSICU work at #ESICM: TCD in acute liver failure and Code ICH implementation.

Insightful exchange with Fabio Taccone and @romsonnevil.bsky.social.

#LIVES2025 #NeurocriticalCare #NSICU #TCD @esicm.bsky.social
October 27, 2025 at 8:36 PM
Honored to see our Milrinone study on DCI and vasospasm in aSAH featured at CNS 2025 in Los Angeles.

#CNS2025 #2025CNS
#Neurosurgery #NeurocriticalCare
#LosAngeles
#CatholichealthLI
#NorthwellHealth
@CNS_Update
October 13, 2025 at 8:22 PM
Shared our Code ICH project at the @neurocritical.bsky.social Annual Meeting 2025 with Dr. David Ledoux and team. Proud to see this work grow into multi-center collaborations for better ICH care.

#NeurocriticalCare
#Stroke #NCS2025
#Canada
#StFrancisHeartCenter
#CatholicHealth
#NorthwellHealth
September 24, 2025 at 1:44 PM
Reposted by Eveline M Gutzwiller
Horvat et al: Ketamine Versus Midazolam as the First-Line Continuous Infusion for Status Epilepticus in Children with Cardiac Disease

Link: link.springer.com/ar...

@neurocritical #neurocritcare
Ketamine Versus Midazolam as the First-Line Continuous Infusion for Status Epilepticus in Children with Cardiac Disease
Neurocritical Care - The treatment of status epilepticus (SE) in children with cardiac disease is challenging given their often-tenuous hemodynamic state. We aim to determine whether ketamine is...
link.springer.com
May 9, 2025 at 12:00 PM
Reposted by Eveline M Gutzwiller
Pulmonary embolism in ICU patients carries high mortality. Timely diagnosis, risk stratification, and tailored therapies—ranging from anticoagulation to advanced reperfusion—are essential to improve outcomes and manage complications effectively. zurl.co/7RLZr
April 19, 2025 at 4:00 PM
Reposted by Eveline M Gutzwiller
LV diastolic dysfunction is common in septic shock but not linked to mortality under 2016 guidelines. Its reversibility and reliance on filling pressures highlight the need for tailored ICU management and updated clinical approaches. zurl.co/LOSRi
April 21, 2025 at 4:00 PM
Reposted by Eveline M Gutzwiller
ECMO with intra-aortic balloon pump reduced mortality in cardiogenic shock compared to no support. Other devices showed no clear benefit. Findings are based on high-quality randomised and propensity score-matched studies. zurl.co/11FCx
April 22, 2025 at 8:00 AM
Reposted by Eveline M Gutzwiller
Highly malignant EEG patterns after cardiac arrest predict poor outcomes with 93% specificity, rising to 97% when EEG is unreactive, though accuracy is lower than in prior studies, supporting a multimodal prognostication approach. zurl.co/qZUst
April 24, 2025 at 4:00 PM
Reposted by Eveline M Gutzwiller
April 19, 2025 at 12:25 PM